M&A Deal Summary |
|
|---|---|
| Date | 2022-11-08 |
| Target | Alcami |
| Sector | Life Science |
| Buyer(s) |
Vistria Group
GHO Capital Partners |
| Sellers(s) |
Madison Dearborn Partners
Ampersand Capital Partners |
| Deal Type | Secondary Buyout |
| Advisor(s) | Morgan Stanley (Financial) Kirkland & Ellis (Legal) |
SEARCH BY
The Vistria Group is a middle-market private equity firm focused on the education, healthcare, and financial services industries. Vistria was formed in 2013 and is based in Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 26 of 30 |
| Sector: Life Science M&A | 5 of 5 |
| Type: Secondary Buyout M&A Deals | 10 of 14 |
| State: North Carolina M&A | 2 of 2 |
| Country: United States M&A | 26 of 30 |
| Year: 2022 M&A | 7 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-28 |
Sandstone Care
Denver, Colorado, United States Sandstone Care is a provider of high-quality care for young people with a variety of behavioral and mental health conditions including depression, anxiety, suicidal tendencies, substance use disorder, or any set of co-occurring conditions. Sandstone Care was founded in 2015 and is based in Denver, Colorado. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-15 |
MGT
Tampa, Florida, United States MGT is a provider of social impact and performance improvement solutions for public agencies, philanthropic organizations, and Fortune 500 companies across the U.S. and abroad. The company has expanded its education and technology solutions portfolio with the addition of Davis Demographics, EH&A, Kitamba, Ed Direction, Cira Infotech, Layer 3 Communications, and Step By Step Learning. It provides highly specialized solutions addressing mission-critical client priorities that improve outcomes and helps organizations and communities thrive. MGT was founded in 1975 and is based in Tampa, Florida. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2014 |
| PE ASSETS | 6.0B EUR |
| Size | Mega |
| Type | Sector Focused |
GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 20 of 25 |
| Sector: Life Science M&A | 13 of 16 |
| Type: Secondary Buyout M&A Deals | 10 of 12 |
| State: North Carolina M&A | 3 of 3 |
| Country: United States M&A | 9 of 12 |
| Year: 2022 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-11 |
RoslinCT
Edinburgh, United Kingdom RoslinCT is a global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. RoslinCT is based in Edinburgh, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-12-01 |
Sapio Sciences
Baltimore, Maryland, United States Sapio Sciences is a lab informatics platform providing LIMS, ELN and Data management solutions to Biopharma, CROs and clinical diagnostic labs. Sapio Sciences was founded in 2004 and is based in Baltimore, Maryland. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 31.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Madison Dearborn Partners (MDP) is a large private equity firm that targets buyouts of private or publicly held companies, divestitures of larger companies, recapitalizations of family-owned or closely-held companies, acquisition-oriented financings, and financings to fund internal growth. MDP's target investment size is $100 to $600 million in buyout oriented transactions and $100 to $400 million in growth capital commitments. Areas of interest include basic industries (natural resources, chemicals, energy and power, automotive, building products, food, metals and mining, refining, paper, packaging and forest products, and general manufacturing), as well as communications, consumer products/services, financial services, and healthcare. Madison Dearborn Partners was formed in 1992 and is based in Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 69 of 79 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Secondary Buyout M&A Deals | 13 of 14 |
| State: North Carolina M&A | 1 of 1 |
| Country: United States M&A | 60 of 69 |
| Year: 2022 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-08-01 |
EVO
Atlanta, Georgia, United States EVO is a payment technology and services provider that offers an array of innovative, reliable, and secure payment solutions to merchants across the globe EVO was founded in 1989 and is based in Atlanta, Georgia. |
Sell | $4.0B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-12-19 |
Great Gray Trust
Las Vegas, Nevada, United States Great Gray Trust is a service provider to collective investment trust (“CIT”) asset managers and qualified retirement plans and their advisors. Great Gray provides trustee services, including managing and monitoring the CIT’s investment advisors and their compliance with the CIT’s investment policy. Great Gray also provides critical administrative services, including regulatory compliance, governance and reporting, fund onboarding, and fund audit and accounting, as well as sales support. Great Gray Trust is based in Las Vegas, Nevada. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 54 of 56 |
| Sector: Life Science M&A | 24 of 26 |
| Type: Secondary Buyout M&A Deals | 6 of 6 |
| State: North Carolina M&A | 4 of 4 |
| Country: United States M&A | 51 of 51 |
| Year: 2022 M&A | 7 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-10-03 |
GenDx
Utrecht, Netherlands GenDx is a Dutch company specializing in Molecular Diagnostics, focused on the development, production, and sales of innovative assays and analysis software for transplantation and companion diagnostics. GenDx specializes in HLA sequencing-based typing strategies and offers reagents and software for both Sanger and NGS approaches. GenDx was founded in 2005 and is based in Utrecht, Netherlands. |
Sell | €135M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-05-02 |
P95
Leuven, Belgium P95 is a global provider of clinical and epidemiology research solutions with a specialty focus on vaccines and infectious diseases. P95 offers a wide range of solutions including phase I-IV clinical studies, epidemiology, and RWE studies, in addition to scientific and clinical development consulting. It provides end-to-end services including study start-up, clinical monitoring, sample management, medical monitoring and pharmacovigilance, qualitative research, medical writing, data management, biostatistics, and IT. P95 was founded in 2011 and is based in Leuven, Belgium. |
Buy | - |
